DK
Dongwon Kim
About Dongwon Kim
Data last updated:
Dongwon Kim is a Director at Nuerepa Biotechnology Private Limited (since 2023). The company operates in Healthcare. Nuerepa Biotechnology Private Limited reported revenue of ₹73,835 (FY 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nuerepa Biotechnology Private Limited U51909DL2020FTC374559 | Director | 26 May 2023 | 2020 | ₹73,835 (FY 2021) | Active |
Board colleagues of Dongwon Kim
| Name | DIN | Company | Designation |
|---|---|---|---|
| Hyungjin Shin | 08997333 | Nuerepa Biotechnology Private Limited | Director |
| Sudha Kumari | 08997334 | Nuerepa Biotechnology Private Limited | Director |
| Young Sik Kim | 07505116 | Nuerepa Biotechnology Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dongwon Kim
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dongwon Kim
Dongwon Kim currently holds 1 directorship: Nuerepa Biotechnology Private Limited (Director, since 26 May 2023, revenue ₹73,835 (FY 2021)).
Dongwon Kim was first appointed on 26 May 2023 as Director at Nuerepa Biotechnology Private Limited.
The current boards of Dongwon Kim's companies include Hyungjin Shin (Nuerepa Biotechnology Private Limited), Sudha Kumari (Nuerepa Biotechnology Private Limited), Young Sik Kim (Nuerepa Biotechnology Private Limited).